BABA

Alibaba Group Holding Limited

53
Fundamentals36/ 100
Valuation50/ 100
Upside potential58/ 100
Risk potential23/ 100

BABA offers stronger valuation, but that advantage does not outweigh its weaker overall profile.

WEYS

Weyco Group, Inc.

58
Fundamentals77/ 100
Valuation29/ 100
Upside potential51/ 100
Risk potential23/ 100

WEYS has the edge over BABA overall, supported by stronger fundamentals.

BABA Fundamentals

MetricStatus
Stable
Under pressure
Weak
Healthy

BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.

WEYS Fundamentals

MetricStatus
Stable
Strong
Strong
Strong

WEYS's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.

BABA PE Valuation

CHEAPFAIREXPENSIVE9.3x19x28x37x
CHEAPFAIREXPENSIVE9.3x19x28x37x
LevelPEPriceVs current
Cheap16x$69.66-26%
Fair20x$86.59-8.2%
Current21x$94.36—
Expensive26x$115+22%

Historical ranges are pointers, not guarantees.

BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.

WEYS PE Valuation

CHEAPFAIREXPENSIVE15x29x44x58x
CHEAPFAIREXPENSIVE15x29x44x58x
LevelPEPriceVs current
Cheap8.6x$35.65-40%
Fair11x$45.12-25%
Expensive14x$59.32-0.8%
Current14x$59.77—

Historical ranges are pointers, not guarantees.

WEYS has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.

BABA Forward outlook

MetricOutlook
--
Strong growth
Growth
Strongly improving
Limited
Low

Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.

WEYS Forward outlook

There aren't enough analyst estimates for WEYS to show an outlook.

BABA Risk to reward

ScenarioChangePrice
Upside+33%$125.09
Downside-23%$72.35

Calculated from the latest close: $94.36 on Nov 12.

BABA has a better modeled risk to reward balance than WEYS, with more potential upside relative to its potential downside.

WEYS Risk to reward

ScenarioChangePrice
Upside+24%$73.87
Downside-23%$46.06

Calculated from the latest close: $59.77 on Nov 12.

WEYS trails BABA on modeled risk to reward, with less potential upside relative to its potential downside.

BABA Earnings Per Share

Q3 2023: $8.12Q4 2023: $6.04Q1 2024: $4.71Q2 2024: $4.29Q3 2024: $5.26Q4 2024: $7.47Q1 2025: $8.06Q2 2025: $9.27Q3 2025: $7.85Q4 2025: $5.79Q1 2026: $6.57Q2 2026: $4.42
Q3 2023: $8.12Q4 2023: $6.04Q1 2024: $4.71Q2 2024: $4.29Q3 2024: $5.26Q4 2024: $7.47Q1 2025: $8.06Q2 2025: $9.27Q3 2025: $7.85Q4 2025: $5.79Q1 2026: $6.57Q2 2026: $4.42
QuarterTTM EPSYoY
Q2 2026$4.42-52%
Q1 2026$6.57-18%
Q4 2025$5.79-22%
Q3 2025$7.85+49%
Q2 2025$9.27+116%
Q1 2025$8.06+71%
Q4 2024$7.47+24%
Q3 2024$5.26-35%

BABA has the edge over WEYS on earnings, with more consistent year-over-year improvement.

WEYS Earnings Per Share

Q4 2023: $3.17Q1 2024: $3.08Q2 2024: $3.17Q3 2024: $3.03Q4 2024: $3.16Q1 2025: $3.04Q2 2025: $2.69Q3 2025: $2.54Q4 2025: $2.41Q1 2026: $2.48Q2 2026: $3.63Q3 2026: $4.13
Q4 2023: $3.17Q1 2024: $3.08Q2 2024: $3.17Q3 2024: $3.03Q4 2024: $3.16Q1 2025: $3.04Q2 2025: $2.69Q3 2025: $2.54Q4 2025: $2.41Q1 2026: $2.48Q2 2026: $3.63Q3 2026: $4.13
QuarterTTM EPSYoY
Q3 2026$4.13+63%
Q2 2026$3.63+35%
Q1 2026$2.48-18%
Q4 2025$2.41-24%
Q3 2025$2.54-16%
Q2 2025$2.69-15%
Q1 2025$3.04-1.3%
Q4 2024$3.16-0.3%

WEYS earned $4.13 per share over the past year, up 63% from the year before.

BABA Quarterly Revenue

Q3 2023: $33.7BQ4 2023: $39.1BQ1 2024: $33.3BQ2 2024: $36.5BQ3 2024: $35.5BQ4 2024: $42BQ1 2025: $35.5BQ2 2025: $37.2BQ3 2025: $37.2BQ4 2025: $42.7BQ1 2026: $36.5BQ2 2026: $40.2B
Q3 2023: $33.7BQ4 2023: $39.1BQ1 2024: $33.3BQ2 2024: $36.5BQ3 2024: $35.5BQ4 2024: $42BQ1 2025: $35.5BQ2 2025: $37.2BQ3 2025: $37.2BQ4 2025: $42.7BQ1 2026: $36.5BQ2 2026: $40.2B
QuarterRevenueYoY
Q2 2026$40.2B+8.3%
Q1 2026$36.5B+2.9%
Q4 2025$42.7B+1.7%
Q3 2025$37.2B+4.8%
Q2 2025$37.2B+1.8%
Q1 2025$35.5B+6.6%
Q4 2024$42B+7.6%
Q3 2024$35.5B+5.2%

BABA has the edge over WEYS on sales, with more consistent year-over-year improvement.

WEYS Quarterly Revenue

Q4 2023: $81MQ1 2024: $72MQ2 2024: $64MQ3 2024: $74MQ4 2024: $80MQ1 2025: $68MQ2 2025: $58MQ3 2025: $73MQ4 2025: $77MQ1 2026: $68MQ2 2026: $62MQ3 2026: $77M
Q4 2023: $81MQ1 2024: $72MQ2 2024: $64MQ3 2024: $74MQ4 2024: $80MQ1 2025: $68MQ2 2025: $58MQ3 2025: $73MQ4 2025: $77MQ1 2026: $68MQ2 2026: $62MQ3 2026: $77M
QuarterRevenueYoY
Q3 2026$77M+5.3%
Q2 2026$62.2M+6.9%
Q1 2026$68M0%
Q4 2025$76.8M-4.6%
Q3 2025$73.1M-1.6%
Q2 2025$58.2M-8.9%
Q1 2025$68M-4.9%
Q4 2024$80.5M-0.1%

WEYS's revenue is recovering but still below its 2021 peak: $77M last quarter, up 5.3% from the same quarter a year ago.

BABA Free Cash Flow

Q3 2023: $5.4BQ4 2023: $11BQ1 2024: $34MQ2 2024: $3.2BQ3 2024: $2.1BQ4 2024: $10.4BQ1 2025: −$4.2BQ2 2025: −$2.7BQ3 2025: −$3.2BQ4 2025: $1BQ1 2026: −$2.7BQ2 2026: −$6.7B
Q3 2023: $5.4BQ4 2023: $11BQ1 2024: $34MQ2 2024: $3.2BQ3 2024: $2.1BQ4 2024: $10.4BQ1 2025: −$4.2BQ2 2025: −$2.7BQ3 2025: −$3.2BQ4 2025: $1BQ1 2026: −$2.7BQ2 2026: −$6.7B
QuarterFree cash flowYoY
Q2 2026-$6.7B-$4.1B
Q1 2026-$2.7B+$1.5B
Q4 2025$1B-90%
Q3 2025-$3.2B-254%
Q2 2025-$2.7B-182%
Q1 2025-$4.2B-12231%
Q4 2024$10.4B-4.8%
Q3 2024$2.1B-62%

BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.

WEYS Free Cash Flow

Q4 2023: $35MQ1 2024: $14MQ2 2024: $3MQ3 2024: −$930,000Q4 2024: $20MQ1 2025: $4MQ2 2025: $10MQ3 2025: −$1MQ4 2025: $23MQ1 2026: $17MQ2 2026: $7MQ3 2026: $990,000
Q4 2023: $35MQ1 2024: $14MQ2 2024: $3MQ3 2024: −$930,000Q4 2024: $20MQ1 2025: $4MQ2 2025: $10MQ3 2025: −$1MQ4 2025: $23MQ1 2026: $17MQ2 2026: $7MQ3 2026: $990,000
QuarterFree cash flowYoY
Q3 2026$990K+$2.3M
Q2 2026$6.8M-32%
Q1 2026$16.9M+355%
Q4 2025$23.1M+16%
Q3 2025-$1.3M-$393K
Q2 2025$10M+216%
Q1 2025$3.7M-74%
Q4 2024$19.9M-43%

WEYS has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.

BABA Total Shares

Q3 2023: 2.6BQ4 2023: 2.5BQ1 2024: 2.5BQ2 2024: 2.4BQ3 2024: 2.4BQ4 2024: 2.4BQ1 2025: 2.4BQ2 2025: 2.4BQ3 2025: 2.4BQ4 2025: 2.4BQ1 2026: 2.4BQ2 2026: 2.4B
Q3 2023: 2.6BQ4 2023: 2.5BQ1 2024: 2.5BQ2 2024: 2.4BQ3 2024: 2.4BQ4 2024: 2.4BQ1 2025: 2.4BQ2 2025: 2.4BQ3 2025: 2.4BQ4 2025: 2.4BQ1 2026: 2.4BQ2 2026: 2.4B
PeriodChange %Net change
Quarterly+0.5%+11.1M shares
1 year+0.9%+21.4M shares
3 years-6.2%-161M shares
5 years-12%-339M shares
Available history-8.4%-221M shares

BABA has the edge over WEYS on shareholder dilution, with a more favorable share count trend.

WEYS Total Shares

Q4 2023: 10MQ1 2024: 10MQ2 2024: 10MQ3 2024: 10MQ4 2024: 10MQ1 2025: 10MQ2 2025: 10MQ3 2025: 10MQ4 2025: 10MQ1 2026: 10MQ2 2026: 10MQ3 2026: 10M
Q4 2023: 10MQ1 2024: 10MQ2 2024: 10MQ3 2024: 10MQ4 2024: 10MQ1 2025: 10MQ2 2025: 10MQ3 2025: 10MQ4 2025: 10MQ1 2026: 10MQ2 2026: 10MQ3 2026: 10M
PeriodChange %Net change
Quarterly+0.9%+90K shares
1 year+1.2%+116K shares
3 years+1.3%+121K shares
5 years-1.1%-106K shares
Available history-3%-302K shares

WEYS has 10M diluted shares, up 1.2% from a year ago.

BABA Net Leverage

Q3 2023: -0.6xQ4 2023: -0.8xQ1 2024: -0.4xQ2 2024: -0.4xQ3 2024: -0.2xQ4 2024: 0.1xQ1 2025: 0.3xQ2 2025: 0.2xQ3 2025: 0.8xQ4 2025: 0.6xQ1 2026: 0.5xQ2 2026: 0.5x
Q3 2023: -0.6xQ4 2023: -0.8xQ1 2024: -0.4xQ2 2024: -0.4xQ3 2024: -0.2xQ4 2024: 0.1xQ1 2025: 0.3xQ2 2025: 0.2xQ3 2025: 0.8xQ4 2025: 0.6xQ1 2026: 0.5xQ2 2026: 0.5x
QuarterNet LeverageStatus
Q2 20260.5xVery low
Q1 20260.5xVery low
Q4 20250.6xVery low
Q3 20250.8xVery low
Q2 20250.2xVery low
Q1 20250.3xVery low
Q4 20240.1xVery low
Q3 2024-0.2xNet Cash

BABA's net debt is less than a year of its operating earnings (EBITDA).

WEYS Net Leverage

Q1 2024: -1.9xQ2 2024: -1.9xQ3 2024: -1.9xQ4 2024: -1.8xQ1 2025: -1.9xQ2 2025: -2.2xQ3 2025: -2.2xQ4 2025: -3.0xQ1 2026: -2.7xQ2 2026: -2.1xQ3 2026: -1.8x
Q1 2024: -1.9xQ2 2024: -1.9xQ3 2024: -1.9xQ4 2024: -1.8xQ1 2025: -1.9xQ2 2025: -2.2xQ3 2025: -2.2xQ4 2025: -3.0xQ1 2026: -2.7xQ2 2026: -2.1xQ3 2026: -1.8x
QuarterNet LeverageStatus
Q3 2026-1.8xNet Cash
Q2 2026-2.1xNet Cash
Q1 2026-2.7xNet Cash
Q4 2025-3.0xNet Cash
Q3 2025-2.2xNet Cash
Q2 2025-2.2xNet Cash
Q1 2025-1.9xNet Cash
Q4 2024-1.8xNet Cash

WEYS has the edge over BABA on leverage, with a lower net debt burden relative to earnings.

BABA Weekly Momentum

MetricValueStatus
RSI38.0Neutral
Stochastic12.7Oversold

BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).

WEYS Weekly Momentum

MetricValueStatus
RSI81.4Overbought
Stochastic76.8Neutral

WEYS's weekly RSI is 81 (overbought) and its Stochastic is 77 (neutral).

BABA PE vs Consumer Cyclical Sector

MetricBABASector medianRelative
PE21x18x19% above
PE %604713 pts above

BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.

WEYS PE vs Consumer Cyclical Sector

MetricWEYSSector medianRelative
PE14x18x20% below
PE %844737 pts above

WEYS has the edge over BABA on valuation relative to its sector.

BABA Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$104.79.9% below
20 week MA$111.115% below
50 week MA$128.026% below
100 week MA$127.726% below
200 week MA$106.411% below

BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.

WEYS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$53.212% above
20 week MA$46.828% above
50 week MA$38.655% above
100 week MA$35.170% above
200 week MA$32.485% above

WEYS has the edge over BABA on trend strength, trading above more of its moving averages.

BABA Yearly ROI

YearStart priceEnd priceROI
2020$215.5$222.0+3%
2021$222.0$118.7-47%
2022$118.7$85.7-28%
2023$85.7$77.5-9.5%
2024$77.5$85.1+9.7%
2025$85.1$152.2+79%
2026 YTD$152.2$94.4-38%

BABA has finished lower in three of the last six years. It's down 38% so far in 2026.

WEYS Yearly ROI

YearStart priceEnd priceROI
2020$26.6$16.3-39%
2021$16.3$22.8+39%
2022$22.8$24.4+7%
2023$24.4$31.4+29%
2024$31.4$37.2+19%
2025$37.2$31.3-16%
2026 YTD$31.3$59.8+91%

WEYS has the edge over BABA on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key